ATE168414T1 - Aprotininanaloga - Google Patents

Aprotininanaloga

Info

Publication number: ATE168414T1
Authority: AT; Austria
Prior art keywords: aminoacid; replaced; residue; negatively charged; aminoacid residue
Prior art date: 1990-10-01

Application number

AT91917143T

Other languages

English (en)

Inventor

Soren Erik Bjorn

Kjeld Norris

Viggo Diness

Leif Birkeve Norskov-Lauritsen

Niels Dyhr Christensen

Claus Bregengaard

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-01

Filing date

1991-10-01

Publication date

1998-08-15

1990-10-01 Priority claimed from DK236190A external-priority patent/DK236190D0/da

1991-06-12 Priority claimed from DK111891A external-priority patent/DK111891D0/da

1991-10-01 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1998-08-15 Application granted granted Critical

1998-08-15 Publication of ATE168414T1 publication Critical patent/ATE168414T1/de

Links

ZPNFWUPYTFPOJU-MPSLMFKFSA-N aprotinin Chemical class CC[C@H](C)[C@@H]1NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H]3NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CSSC[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC3=O)C(=O)N[C@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](CSSC[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H]3CCCN3C(=O)[C@H](N)CCCNC(N)=N)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N3CCC[C@@H]3C(=O)N3CCC[C@H]3C(=O)N[C@H](Cc3ccc(O)cc3)C(=O)N[C@H]([C@H](C)O)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N2)C(=O)NCC(=O)NCC(=O)N[C@H](C)C(O)=O)NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](NC1=O)[C@H](C)CC)[C@@H](C)O)C(C)C ZPNFWUPYTFPOJU-MPSLMFKFSA-N 0.000 title 1
125000000539 amino acid group Chemical group 0.000 abstract 7
230000007935 neutral effect Effects 0.000 abstract 2
206010029155 Nephropathy toxic Diseases 0.000 abstract 1
108091005804 Peptidases Proteins 0.000 abstract 1
239000004365 Protease Substances 0.000 abstract 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical class C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 abstract 1
230000007694 nephrotoxicity Effects 0.000 abstract 1
231100000417 nephrotoxicity Toxicity 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Life Sciences & Earth Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT91917143T 1990-10-01 1991-10-01 Aprotininanaloga ATE168414T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK236190A DK236190D0 (da)	1990-10-01	1990-10-01	Polypeptid
DK111891A DK111891D0 (da)	1991-06-12	1991-06-12	Polypeptid

Publications (1)

Publication Number	Publication Date
ATE168414T1 true ATE168414T1 (de)	1998-08-15

Family

ID=26065261

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91917143T ATE168414T1 (de)	1990-10-01	1991-10-01	Aprotininanaloga

Country Status (21)

Country	Link
EP (1)	EP0551329B1 (de)
JP (1)	JP3614850B2 (de)
KR (1)	KR100250391B1 (de)
AT (1)	ATE168414T1 (de)
AU (1)	AU659100B2 (de)
CA (1)	CA2092920A1 (de)
CZ (1)	CZ285225B6 (de)
DE (1)	DE69129809T2 (de)
DK (1)	DK0551329T3 (de)
ES (1)	ES2121787T3 (de)
FI (1)	FI105036B (de)
HU (1)	HU219302B (de)
IE (1)	IE913433A1 (de)
IL (1)	IL99585A0 (de)
MX (1)	MX9101382A (de)
NO (1)	NO309529B1 (de)
NZ (1)	NZ240014A (de)
PT (1)	PT99124B (de)
SK (1)	SK281540B6 (de)
UA (1)	UA34422C2 (de)
WO (1)	WO1992006111A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6057287A (en)	1994-01-11	2000-05-02	Dyax Corp.	Kallikrein-binding "Kunitz domain" proteins and analogues thereof
AU738766B2 (en) *	1994-11-21	2001-09-27	University Of Leeds, The	Modified proteinase inhibitors
WO1996016173A2 (en) *	1994-11-21	1996-05-30	The University Of Leeds	Modified proteinase inhibitors
DE19629982A1 (de)	1996-07-25	1998-01-29	Bayer Ag	Aprotinin-Varianten mit verbesserten Eigenschaften
DE19725014A1 (de) *	1997-06-13	1998-12-17	Bayer Ag	Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
WO2001066801A2 (en) *	2000-03-08	2001-09-13	Complexe Hospitalier De La Sagamie	Very low density lipoprotein receptor polymorphisms and uses therefor
US7153829B2 (en)	2002-06-07	2006-12-26	Dyax Corp.	Kallikrein-inhibitor therapies
PT2298278E (pt)	2002-06-07	2016-02-25	Dyax Corp	Prevenção e redução da perda de sangue e resposta inflamatória
WO2004019968A1 (en)	2002-08-28	2004-03-11	Dyax Corp.	Methods for preserving organs and tissues
US7235530B2 (en)	2004-09-27	2007-06-26	Dyax Corporation	Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
WO2008077478A1 (en) *	2006-12-22	2008-07-03	Bayer Schering Pharma Aktiengesellschaft	Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
DE102007056231A1 (de)	2007-09-08	2009-03-12	Bayer Healthcare Ag	Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
JP2013516389A (ja)	2009-01-06	2013-05-13	ダイアックスコーポレーション	カリクレイン阻害剤による粘膜炎治療
ES2905545T3 (es)	2010-01-06	2022-04-11	Takeda Pharmaceuticals Co	Proteínas de unión a calicreína plasmática
KR102011156B1 (ko)	2011-01-06	2019-08-16	다이액스 코포레이션	혈장 칼리크레인 결합 단백질
US11286307B2 (en)	2015-12-11	2022-03-29	Takeda Pharmaceutical Company Limited	Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
AU2021209045A1 (en)	2020-01-13	2022-07-28	Takeda Pharmaceutical Company Limited	Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2188322A (en) *	1986-03-26	1987-09-30	Bayer Ag	Aprotinin and analogues thereof produced by a recombinant host
DE3724570A1 (de) *	1987-06-27	1989-01-05	Bayer Ag	Human-aprotinin, dessen lys-rest in position 15 gegen einen anderen protogenen aminosaeurerest ausgetauscht ist
DK450187D0 (da) *	1987-08-28	1987-08-28	Novo Industri As	Fremgangsmaade til fremstilling af proteiner
DK225488D0 (da) *	1988-04-26	1988-04-26	Novo Industri As	Polypeptid
DE3930522A1 (de) *	1989-09-13	1991-03-21	Bayer Ag	Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben

1991
- 1991-09-27 IL IL99585A patent/IL99585A0/xx unknown
- 1991-09-30 IE IE343391A patent/IE913433A1/en not_active Application Discontinuation
- 1991-09-30 PT PT99124A patent/PT99124B/pt not_active IP Right Cessation
- 1991-09-30 NZ NZ240014A patent/NZ240014A/en unknown
- 1991-10-01 UA UA93002097A patent/UA34422C2/uk unknown
- 1991-10-01 AU AU85460/91A patent/AU659100B2/en not_active Ceased
- 1991-10-01 SK SK264-93A patent/SK281540B6/sk unknown
- 1991-10-01 HU HU9300943A patent/HU219302B/hu not_active IP Right Cessation
- 1991-10-01 ES ES91917143T patent/ES2121787T3/es not_active Expired - Lifetime
- 1991-10-01 EP EP91917143A patent/EP0551329B1/de not_active Expired - Lifetime
- 1991-10-01 CZ CZ93517A patent/CZ285225B6/cs not_active IP Right Cessation
- 1991-10-01 MX MX9101382A patent/MX9101382A/es not_active IP Right Cessation
- 1991-10-01 JP JP51609991A patent/JP3614850B2/ja not_active Expired - Fee Related
- 1991-10-01 AT AT91917143T patent/ATE168414T1/de not_active IP Right Cessation
- 1991-10-01 DE DE69129809T patent/DE69129809T2/de not_active Expired - Fee Related
- 1991-10-01 WO PCT/DK1991/000299 patent/WO1992006111A1/en not_active Ceased
- 1991-10-01 CA CA002092920A patent/CA2092920A1/en not_active Abandoned
- 1991-10-01 DK DK91917143T patent/DK0551329T3/da active
1993
- 1993-03-31 FI FI931457A patent/FI105036B/fi active
- 1993-03-31 NO NO931220A patent/NO309529B1/no not_active IP Right Cessation
- 1993-03-31 KR KR1019930701001A patent/KR100250391B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP3614850B2 (ja)	2005-01-26
DE69129809T2 (de)	1998-11-19
CA2092920A1 (en)	1992-04-02
DE69129809D1 (de)	1998-08-20
NO309529B1 (no)	2001-02-12
NO931220L (no)	1993-04-01
IL99585A0 (en)	1992-08-18
NZ240014A (en)	1992-08-26
DK0551329T3 (da)	1999-04-19
HU9300943D0 (en)	1993-06-28
SK281540B6 (sk)	2001-04-09
UA34422C2 (uk)	2001-03-15
CZ51793A3 (en)	1994-01-19
SK26493A3 (en)	1993-10-06
ES2121787T3 (es)	1998-12-16
WO1992006111A1 (en)	1992-04-16
HU219302B (en)	2001-03-28
PT99124A (pt)	1992-08-31
KR100250391B1 (ko)	2000-05-01
PT99124B (pt)	1999-03-31
IE913433A1 (en)	1992-04-08
FI105036B (fi)	2000-05-31
JPH06501158A (ja)	1994-02-10
FI931457A0 (fi)	1993-03-31
AU8546091A (en)	1992-04-28
NO931220D0 (no)	1993-03-31
EP0551329B1 (de)	1998-07-15
AU659100B2 (en)	1995-05-11
CZ285225B6 (cs)	1999-06-16
HUT69955A (en)	1995-09-28
EP0551329A1 (de)	1993-07-21
FI931457L (fi)	1993-03-31
MX9101382A (es)	1992-06-05

Legal Events

Date	Code	Title	Description
1999-01-15	UEP	Publication of translation of european patent specification
2004-07-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69129809D1 (de)	1998-08-20	Aprotininanaloga
DE68900991D1 (de)	1992-04-23	Cyclosporin-zusammensetzungen.
SE8903042L (sv)	1990-05-11	Pharmaceutical compositions comprising cyklosporins
ATE154938T1 (de)	1997-07-15	Inhibitorvariante der menschlichen protease vom kunitz-typ
IT1231852B (it)	1992-01-14	Perfezionamenti alle pinze ad espansione
FI944231L (fi)	1995-03-15	Antitromboottiset tripeptidiaineet
MX9100599A (es)	1992-07-08	Juego con pala
FI912462A0 (fi)	1991-05-21	Tgf-b-kompositioner.
DE68904887D1 (de)	1993-03-25	Mehrteilige ringprothese fuer anuloplastie.
NO910591L (no)	1991-10-28	Lavtaps, analog faseforskyver med nesten 360 grader faseforskyvning i x-baandet.
DE69400872D1 (de)	1996-12-12	Kraftstoffzusammensetzungen
DE69021872D1 (de)	1995-09-28	Modifizierte Lösungsmittelzusammensetzungen.
TR26415A (tr)	1995-03-15	Yumusak sampuan terkipleri
DE69433062D1 (de)	2003-09-25	Ceramid i analoge auf basis von phytosphingosine
ATE210149T1 (de)	2001-12-15	Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
EP0607103A3 (de)	1997-07-09	Chelatbildende Gruppen enthaltende Somatostatinanaloge und deren radiomarkierten Zusammensetzungen.
DE68905762D1 (de)	1993-05-06	Perorale zusammensetzungen.
NO902871L (no)	1991-12-30	Fremgangsmaate for innfoering av et peptid i cytosol.
ITTO910894A1 (it)	1993-05-21	"un procedimento per preparare dipeptidi".
KR870700081A (ko)	1987-02-28	폴리사이클로알케닐-종결, 불포화폴리에스테르 또는 폴리에스테르아미드 조성물 및 이를 위한 비닐-반응성 가소제
DE69111443D1 (de)	1995-08-24	Schlauchzusammensetzung.
FI924321A7 (fi)	1992-09-25	Ruiskutettavat maataloudessa käytettävät koostumukset
DK147667C (da)	1985-05-28	Sokkel for turbokompressor
RU93005177A (ru)	1995-07-20	Аналоги апротинина, днк, вектор, клетка, способ получения аналогов, фармацевтическая композиция, применение аналогов
FR2666822B1 (fr)	1995-08-11	Composition du type a l'acide phosphorique et objet traite avec cette composition.